JP2021533115A5 - - Google Patents
Info
- Publication number
- JP2021533115A5 JP2021533115A5 JP2021505236A JP2021505236A JP2021533115A5 JP 2021533115 A5 JP2021533115 A5 JP 2021533115A5 JP 2021505236 A JP2021505236 A JP 2021505236A JP 2021505236 A JP2021505236 A JP 2021505236A JP 2021533115 A5 JP2021533115 A5 JP 2021533115A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- alkyl
- groups
- substituted
- alkenyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862711575P | 2018-07-29 | 2018-07-29 | |
| US62/711,575 | 2018-07-29 | ||
| PCT/US2019/043868 WO2020028222A1 (en) | 2018-07-29 | 2019-07-29 | Compounds for the treatment of neurological or mitochondrial diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533115A JP2021533115A (ja) | 2021-12-02 |
| JP2021533115A5 true JP2021533115A5 (https=) | 2022-08-05 |
| JPWO2020028222A5 JPWO2020028222A5 (https=) | 2022-08-05 |
Family
ID=69232050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505236A Pending JP2021533115A (ja) | 2018-07-29 | 2019-07-29 | 神経疾患またはミトコンドリア疾患の処置のための化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11771685B2 (https=) |
| EP (1) | EP3829560A4 (https=) |
| JP (1) | JP2021533115A (https=) |
| KR (1) | KR20210071949A (https=) |
| CN (1) | CN112770735A (https=) |
| WO (1) | WO2020028222A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4122458A4 (en) * | 2020-03-17 | 2024-05-01 | Penta Labor Inc. | AGENT ATTENUATING MITOCHONDRIAL DYSFUNCTION |
| IT202100006065A1 (it) * | 2021-03-15 | 2022-09-15 | Univ Degli Studi Padova | Composto per l’uso nel metodo di trattamento delle malattie mitocondriali da disfunzione dei complessi i, ii, iii della catena respiratoria |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195998A (en) | 1974-04-15 | 1980-04-01 | Eastman Kodak Company | CO(III) Complex containing radiation sensitive element with diazo recording layer |
| US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
| US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| WO1993000077A1 (en) | 1991-06-21 | 1993-01-07 | University Of Cincinnati | Orally administrable therapeutic proteins and method of making |
| US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
| ES2105262T3 (es) | 1992-05-18 | 1997-10-16 | Minnesota Mining & Mfg | Dispositivo de suministro de farmaco a traves de las mucosas. |
| US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| FR2742151B1 (fr) * | 1995-12-12 | 1998-03-06 | Innothera Lab Sa | Utilisation de derives de bicycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| WO2005053609A2 (en) * | 2003-11-26 | 2005-06-16 | Guilford Pharmaceuticals Inc. | Methods of nad+-dependent deacetylase inhibitors |
| GB0816269D0 (en) * | 2008-09-05 | 2008-10-15 | Univ Ramot | Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of alzheimers disease |
| CN101712648B (zh) | 2009-11-23 | 2011-11-09 | 南京大学 | 氮杂蒽醌的合成方法 |
| EA201300215A1 (ru) | 2010-08-06 | 2013-07-30 | Эдисон Фармасьютикалз, Инк. | Лечение митохондриальных болезней нафтохинонами |
| EP2601168A4 (en) * | 2010-08-06 | 2013-12-04 | Ampere Life Sciences Inc | TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K |
| WO2012166862A1 (en) * | 2011-06-01 | 2012-12-06 | Wisconsin Alumni Research Foundation | Compositions and methods for treating alzheimer's disease |
| CN102321084B (zh) | 2011-10-13 | 2013-03-13 | 南京大学 | 苯并[c]吡啶并[4,3,2-mn]吖啶-8-酮的合成方法 |
| KR20140030786A (ko) | 2012-09-03 | 2014-03-12 | 희성소재 (주) | 신규한 화합물 및 이를 포함하는 유기전계발광소자 |
| WO2014074976A1 (en) | 2012-11-09 | 2014-05-15 | Musc Foundation For Research Development | Compositions and methods for treating neurological diseases or injury |
| US20150166476A1 (en) * | 2013-12-17 | 2015-06-18 | Yi-Cheng Chen | Methods for treating neurodegenerative diseases associated with aggregation of amyloid-beta |
| CN104761568B (zh) * | 2014-01-03 | 2017-10-10 | 中国科学院上海药物研究所 | 一类四环萘并噁唑衍生物及其制备方法 |
| EP3191087A1 (en) * | 2014-09-12 | 2017-07-19 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| CA2993809C (en) * | 2015-07-30 | 2023-09-05 | Taipei Medical University | Compounds and pharmaceutical composition associated with ubiquitination-proteasome system |
-
2019
- 2019-07-29 WO PCT/US2019/043868 patent/WO2020028222A1/en not_active Ceased
- 2019-07-29 KR KR1020217006237A patent/KR20210071949A/ko not_active Withdrawn
- 2019-07-29 JP JP2021505236A patent/JP2021533115A/ja active Pending
- 2019-07-29 CN CN201980063585.2A patent/CN112770735A/zh active Pending
- 2019-07-29 EP EP19845102.3A patent/EP3829560A4/en active Pending
- 2019-07-29 US US17/264,714 patent/US11771685B2/en active Active
-
2023
- 2023-09-29 US US18/478,261 patent/US20240041849A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2483072C2 (ru) | Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12 | |
| JP2020515610A5 (https=) | ||
| CY1124503T1 (el) | Βοριοφθαλιδια για θεραπευτικη χρηση | |
| JP2021533115A5 (https=) | ||
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| JP2017512789A5 (https=) | ||
| JP2018523665A5 (https=) | ||
| JP2021530442A5 (https=) | ||
| CA2206794A1 (fr) | Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament | |
| RU2005111975A (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| HU229935B1 (en) | Dual action antibiotics | |
| JP2005531488A5 (https=) | ||
| RU2018103873A (ru) | Терапевтические соединения и композиции для лечения социальных расстройств и расстройств, связанных с употреблением психоактивных веществ | |
| JP2013526520A5 (https=) | ||
| RU2013120556A (ru) | 1,2-гидрокси-2-оксо-хинолин-3-карбоксанилиды в качестве активаторов ahr | |
| JP2019527234A5 (https=) | ||
| JP2021524439A5 (https=) | ||
| JP2024123258A (ja) | 睡眠時無呼吸の治療のためのα２‐アドレナリン受容体サブタイプＣ （ＡＬＰＨＡ‐２Ｃ）拮抗薬 | |
| JPWO2020106642A5 (https=) | ||
| JOP20250101A1 (ar) | مشتقات بنز إيميدازول حلقية كمثبطات cGAS | |
| JP2021527650A5 (https=) | ||
| BRPI0518615A2 (pt) | derivados de malonamida | |
| JPWO2020234274A5 (https=) | ||
| JPWO2020028222A5 (https=) | ||
| JP2017516824A5 (https=) |